<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03515460</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE 86854318.8.0000.5272</org_study_id>
    <nct_id>NCT03515460</nct_id>
  </id_info>
  <brief_title>Acute Effects of Oral Carbohydrate and Fat Loads on Systemic Microvascular Endothelial Function in Healthy Individuals.</brief_title>
  <official_title>Acute Effects of Standardized Oral Carbohydrate and Fat Loads, and the Association of Carbohydrate and Fat Loads, on Systemic Microvascular Endothelial Function in Healthy Individuals.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute of Cardiology, Laranjeiras, Brazil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute of Cardiology, Laranjeiras, Brazil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study was designed to evaluate vascular endothelial dysfunction resulting from
      the oral ingestion of high loads of sugar and fat meals in healthy individuals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The chronic and elevated consumption of fat and carbohydrates is associated with the
      initiation and the progression of cardiovascular and metabolic diseases, including diabetes,
      obesity and metabolic syndrome. In general, chronic diseases are related to underlying
      modifiable cardiovascular risk factors, including high blood pressure, high plasma lipids and
      glucose, physical inactivity, overweight and obesity, as well as smoking habits.

      Vascular endothelial dysfunction is one of the earliest findings in the pathophysiology of
      atherosclerosis and also an important predictor of cardiovascular events. Moreover, it has
      already been demonstrated that acute oral ingestion of high loads of sugar and fat meals
      induces transient vascular endothelial dysfunction, which over time could lead to
      cardiovascular disease.

      Thus, the present study aimed at investigating the individual contributions of sugar and fat
      ingestion on systemic microvascular endothelial reactivity.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2018</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>endothelial-dependent microvascular function</measure>
    <time_frame>one day</time_frame>
    <description>alterations in skin microvascular conductance using laser-based methods</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>sugar oral load</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral ingestion of a high carbohydrate meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fat oral load</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral ingestion of a high fat meal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sugar and fat oral loads</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral ingestion of a high carbohydrate and fat meal</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sugar oral load</intervention_name>
    <description>The individuals will receive a sugar oral load (high sugar meal)</description>
    <arm_group_label>sugar oral load</arm_group_label>
    <other_name>dietary intervention</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fat oral load</intervention_name>
    <description>The individuals will a receive fat oral load (high fat meal)</description>
    <arm_group_label>fat oral load</arm_group_label>
    <other_name>dietary intervention</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sugar and fat oral load</intervention_name>
    <description>The individuals will a receive sugar and fat oral load (high sugar and high fat meal)</description>
    <arm_group_label>sugar and fat oral loads</arm_group_label>
    <other_name>dietary intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy individuals presenting body mass index between 18.5 e 24.9 kg/m2

        Exclusion Criteria:

          -  dysglycemia and dyslipidemia

          -  overweight and obesity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>EDUARDO TIBIRICA, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institute of Cardiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eduardo TIBIRICA, MD, Phd</last_name>
    <phone>+55-21-99914-6075</phone>
    <email>etibi@uol.com.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrea Lorenzo, MD, PhD</last_name>
    <phone>+55-21-99531-6994</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Institute of Cardiology, Ministry of Health, Brazil</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>22240-006</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2018</study_first_submitted>
  <study_first_submitted_qc>May 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2018</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Institute of Cardiology, Laranjeiras, Brazil</investigator_affiliation>
    <investigator_full_name>Eduardo Tibirica, MD, PhD</investigator_full_name>
    <investigator_title>Senior Researcher, MD, PhD</investigator_title>
  </responsible_party>
  <keyword>vascular endothelial function</keyword>
  <keyword>systemic microvascular reactivity</keyword>
  <keyword>dysglycemia</keyword>
  <keyword>dyslipidemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

